The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and tolerability of guadecitabine (SGI-110) plus cisplatin in patients (pts) with platinum-refractory germ cell tumors (GCT): Preliminary results from an open label phase 1b study.
 
Neda Hashemi-Sadraei
No Relationships to Disclose
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen; Celgene
Consulting or Advisory Role - Celgene
 
Susan Perkins
No Relationships to Disclose
 
Michael J Spinella
No Relationships to Disclose
 
Fang Fang
No Relationships to Disclose
 
Nasser H. Hanna
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst)
 
Kenneth P Nephew
No Relationships to Disclose
 
Costantine Albany
Stock and Other Ownership Interests - Advaxis
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Seagen
Speakers' Bureau - Bayer; Sanofi
Research Funding - Astex Pharmaceuticals (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Sanofi